Indication

Chronic tubotympanic suppurative otitis media

Chronic tubotympanic suppurative otitis media is a chronic, non-cholesteatomatous inflammatory and infectious disease of the middle ear cleft, primarily involving the eustachian tube and the anteroinferior tympanic cavity. Read more about Chronic tubotympanic suppurative otitis media

7 drugs 7 manufacturers

Advertisement

Drugs that treat it

Common Chronic tubotympanic suppurative otitis media therapies.

Showing 1–7 of 7 drugs

OFLOXACIN

OPHTHALMIC ANTIBACTERIALS·OTITIS EXTERNA·+4
APOTEX CORP

OFLOXACIN

OPHTHALMIC ANTIBACTERIALS·OTITIS EXTERNA·+4
BAUSCH & LOMB P

OFLOXACIN

OTIC ANTIBIOTICS·OTITIS EXTERNA·+4
Amneal Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Chronic tubotympanic suppurative otitis media preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic tubotympanic suppurative otitis media.

Chronic tubotympanic suppurative otitis media is a chronic, non-cholesteatomatous inflammatory and infectious disease of the middle ear cleft, primarily involving the eustachian tube and the anteroinferior tympanic cavity.

Often referred to as the "safe" or benign subtype of chronic suppurative otitis media, it affects both pediatric and adult populations, frequently arising as a sequela of recurrent acute otitis media or eustachian tube dysfunction.

Pathophysiologically, it is defined by persistent mucosal inflammation, a permanent central perforation of the pars tensa of the tympanic membrane, and the absence of bone-eroding cholesteatoma.

Clinically, affected patients present with recurrent or persistent painless, mucoid to mucopurulent otorrhea accompanied by varying degrees of conductive hearing loss.

Personalize your experience

Follow Chronic tubotympanic suppurative otitis media and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it